Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy

For the first time, an AI-based decision support software for breast cancer detection uses patient’s prior exams to refine its prediction of malignancy

0 Comments4 Minutes

Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D

The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States

0 Comments11 Minutes

Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis

AI-powered reading aid for screening 2D & 3D mammography improves Radiologists’ performance in cancer detection

0 Comments4 Minutes

Come & meet us at the Journées Francophones de Radiologie

Therapixel exhibits at the JFR 2019. Come by our booth #138 to learn how to improve accuracy of breast cancer screening with our AI Software.

0 Comments1 Minutes

Therapixel runs against breast cancer

Therapixel ran ODYSSEA marathon to support the fight against breast cancer. We are honored to participate in Breast Cancer Awareness campaign!

0 Comments2 Minutes


October 3-5, 2019 Budapest, Hungary / Booth 20

0 Comments1 Minute